MAPT and Alzheimer disease: These findings suggest that AD pathogenesis arises not from a single dysfunctional pathway, but rather from a convergence of disrupted immune regulation, lipid homeostasis, and vesicular trafficking, all of which interact with and potentially exacerbate amyloid and tau pathology.